72579-0025 BEQALZI - CanMED: NDC

Product NDC:

72579-0025

Brand Name:

BEQALZI

Generic Name:

Sonrotoclax

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: SONROTOCLAX

Strength: 20.0

Unit: mg/1

Packages:

Code: 72579-0025-01

Description: 1 BLISTER PACK in 1 CARTON (72579-025-01) / 11 TABLET, FILM COATED in 1 BLISTER PACK

Effective Date: Aug. 31, 2026

Discontinued:

Code: 72579-0025-02

Description: 1 BLISTER PACK in 1 CARTON (72579-025-02) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Effective Date: Aug. 31, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

BCL-2

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox